ArticleBMC medical imaging2026
Impact of maras powder on mandibular bone microarchitecture: a fractal and radiomorphometric study.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to examine how maras powder (MP) affects on the cortical and trabecular bone of the mandible using the radiomorphometric indexes and fractal dimension (FD).
methodsA retrospective analysis of radiographic records of 150 male individuals, 50 of whom used MP, 50 of whom smoked cigarettes, and 50 of whom were healthy and did not use any tobacco derivatives, was performed. Cortical bone was evaluated with mandibular cortical width (MCW) and panoramic mandibular index (PMI). Trabecular bone in mandibular anterior was evaluated by FD. The ANOVA test was used to compare normally distributed variables across the three groups, and the Kruskal Wallis test was used to compare non-normally distributed variables across the three groups.
resultsThe mean age of MP users was 42.92 ± 10.21; in smokers, 40.46 ± 10.51; and in the healthy control group, 40 ± 15.05. When the FD measurements were examined in regions of interest (ROI) 1, ROI 2, ROI 3, and the mean ROI values, no significant difference was found between the three groups in terms of FD (p > 0.05), but the fractal dimension was found to be lower in individuals using MP. No significant difference was found between the groups in terms of histogram values and MCW and PMI measurements (p > 0.05).
conclusionNo significant differences were found between users of MP, smokers, and healthy individuals. However, the decreasing trend in FD values may indicate early effects of MP. Studies with larger sample sizes and advanced imaging techniques are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.